ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/(S)-2-((ethoxycarbonyl)amino)-3,3-dimethylbutanoic acid
C9H17NO4
203.24 g/mol
Pharmaceutical Intermediate

(S)-2-((ethoxycarbonyl)amino)-3,3-dimethylbutanoic acid

CAS156990-58-8
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

This compound is a pharmaceutical intermediate designed for use in peptide synthesis. It features a protected amino acid structure with tert-butyl and ethoxycarbonyl groups, making it suitable for solid-phase or solution-phase peptide assembly.

Pharmaceutical intermediate for peptide synthesisBuilding block in the manufacture of therapeutic peptides

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing (S)-2-((ethoxycarbonyl)amino)-3,3-dimethylbutanoic acid?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

Ethyl isonicotinate

CAS1570-45-2

pharmaceutical intermediate

ReferenceSame Category

(R)-2-Methylpyrrolidine-1-carboxylic acid tert-butyl ester

CAS157007-54-0

pharmaceutical intermediate

ReferenceSame Category

1-Cbz-4-Aminomethylpiperidine

CAS157023-34-2

pharmaceutical intermediate

ReferenceSame Category

4-Bromo-2-nitro-6-(trifluoromethyl)aniline

CAS157026-18-1

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-2-(ethoxycarbonylamino)-3,3-dimethylbutanoic acid

InChIKey

BGWONUWPOUBGIO-ZCFIWIBFSA-N

SMILES

CCOC(=O)N[C@H](C(=O)O)C(C)(C)C

Synonyms (2)

—

Sourcing (S)-2-((ethoxycarbonyl)amino)-3,3-dimethylbutanoic acid?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→